Cyclo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Cyclo Therapeutics

15/05/2023 14:31

* Cyclo Therapeutics Inc  CYTH.OQ  reported a quarterly
adjusted
loss of 46 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 42 cents
per share.
    * Revenue fell 22% to $152.00 thousand from a year ago;
analysts
expected $380.00 thousand. 
    * Cyclo Therapeutics Inc's reported EPS for the quarter was
a loss
of 46 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cyclo Therapeutics Inc shares had risen by 44.0% this
quarter and lost 14.8% so far this year.
    * The company reported a quarterly loss of $5.01 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.42          -0.46          Missed
 Dec. 31 2022      -0.25          -0.59          Missed
 Sep. 30 2022      -0.53          -0.50          Beat
 Jun. 30 2022      -0.49          -0.41          Beat